Leila Alland, Chief Medical Officer at PMV Pharmaceuticals, Inc. (PMVP), sold 7,842 shares at $34.80 ($273K) on 2021-05-07, disclosed to the SEC on 2021-05-10.
Open-market sale of $273k PMVP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.80 | 3,842 | $134K | 49.0% |
| 2 | $34.80 | 3,842 | $134K | 49.0% |
| 3 | $35.49 | 158 | $6K | 2.1% |
| Total | $34.81 avg | 7,842 | $273K | 100% |
| Filing → |
| ABEO | BUY | 2024-05-20 | $52K | — | Filing → |
| ABEO | SELL | 2023-09-29 | $28K | — | Filing → |
| PMVP | SELL | 2023-09-18 | $42K | — | Filing → |